Le Lézard
Classified in: Health
Subject: EXE

Statement from the Minister of Health Regarding the Opioid Crisis

OTTAWA, Dec. 7, 2017 /CNW/ - Today, the Honourable Ginette Petitpas Taylor, Minister of Health, issued the following statement:

"I am concerned and saddened by the latest data on opioid-related overdose deaths from Ontario.

"Each opioid-related death is a lost family member, friend, community member and Canadian. We must all take a moment to acknowledge the immense loss for the communities and families impacted by this crisis across this country.

"These numbers confirm that the current crisis is worsening despite our collective efforts to date. Every day, individual Canadians from all walks of life and all parts of the country are losing their lives to this crisis. And the numbers continue to climb. I believe this crisis requires a comprehensive whole-of-government response. It is absolutely critical that we address both the immediate crisis and the longer-term factors at the roots of problematic substance use.

"As Canadians may be aware, last month I announced that Health Canada would authorize emergency overdose prevention sites for those provinces and territories that request them. These facilities are meant as an immediate short-term response to save lives. Today, the Government of Ontario formally requested approval for overdose prevention facilities in the province. I have already spoken with Ontario Health Minister Dr. Eric Hoskins to discuss the situation. I am pleased to say that Health Canada has now received all of the documentation from Ontario and has granted its request for a class exemption. This emergency measure echoes the efforts taken in British Columbia to address the crisis in that province.

"These overdose prevention sites are one step in what has been and will continue to be a concerted and urgent response to this crisis.

"This crisis is unlike any other public health crisis we have experienced in recent years. For that reason, I am committed to moving quickly on my mandate to review Canada's framework for dealing with public health emergencies in collaboration with the Minister of Public Safety and Emergency Preparedness. Through this review, I have asked Health Canada and the Public Health Agency of Canada to identify any additional measures or powers that would help me, as Minister of Health, address the current crisis and any similar crisis in future.   

"I am committed to making sure that we have the appropriate resources and tools needed to address this crisis. Whether it is increasing access to treatment services for all Canadians, reducing systemic barriers like stigma that prevent people from receiving help, or expanding the evidence base to inform and evaluate our response, the Government of Canada will continue to work hand-in-hand with the provinces and territories, health professionals, front-line workers and people with lived and living experience to reverse the trend of opioid overdoses and deaths in Canada."


SOURCE Health Canada

These press releases may also interest you

at 07:03
Emerald Health Therapeutics, Inc. (Emerald) has signed a definitive agreement  ("Agreement") to acquire the remaining shares of Northern Vine Canada Inc. (Northern Vine), owned by Abattis Bioceuticals Corp. (Abattis) , for $2 million in cash and...

at 07:00
Barcotm Uniforms today announced that its globally popular Grey's Anatomytm scrub collection has expanded its product line with new tops and bottoms for men and women that now incorporate spandex-stretch, providing unrivaled comfort and flexibility...

at 07:00
According to a new report published by Allied Market Research, titled, "Endoscope + Radiofrequency Ablation (RFA) Market by Application: Global Opportunity Analysis and Industry Forecast, 2017-2025," the global endoscope + radiofrequency ablation...

at 07:00
Concordia International Corp. ("Concordia" or the "Company") , an international specialty pharmaceutical company focused on becoming a leader in European specialty, off-patent medicines, today announced that as a result of the Company's decision not...

at 07:00
BELLUS Health Inc. ("BELLUS Health" or the "Company"), a biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, today announced that the Japan Patent Office has issued a decision to grant...

at 06:45
The U.S. label for Eli Lilly and Company's once-weekly Trulicity® (dulaglutide) is updated to show the medicine's safety and efficacy in people with type 2 diabetes who have moderate to severe chronic kidney disease (CKD). The label now includes...

News published on 7 december 2017 at 15:35 and distributed by: